Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape-Reference-Cited by-同舟云学术

Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape

Published:2021-06 Issue: Volume:507 Page:97-111
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Lee Ji Eun,Kang Yeo Wool,Jung Kyung Hee,Son Mi Kwon,Shin Seung-Min,Kim Ji-Sun,Kim Soo Jung,Fang Zhenghuan,Yan Hong Hua,Park Jung Hee,Yoon Young-Chan,Han Boreum,Cheon Min Ji,Woo Min Gyu,Seo Myung Sung,Lim Joo Han,Kim Yong-Sung,Hong Soon-Sun

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. Mutant KRAS is a druggable target for pancreatic cancer;Zorde Khvalevsky;Proc. Natl. Acad. Sci. U. S. A.,2013

2. Neoadjuvant therapy for non-metastatic pancreatic ductal adenocarcinoma;Winner;Semin. Oncol.,2015

3. Gemcitabine loaded microbubbles for targeted chemo- sonodynamic therapy of pancreatic cancer;Nesbitt;J. Contr. Release,2018

4. KRAS: feeding pancreatic cancer proliferation;Bryant;Trends Biochem. Sci.,2014

5. Oncogenic KRAS signalling in pancreatic cancer;Eser;Br. J. Canc.,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer;Cellular Oncology;2024-04-15

2. Inhibition of ADAM9 promotes the selective degradation of KRAS and sensitizes pancreatic cancers to chemotherapy;Nature Cancer;2024-01-24

3. Intracellular Protein Delivery: Approaches, Challenges, and Clinical Applications;BME Frontiers;2024-01

4. Signalling in pancreatic cancer: from pathways to therapy;Journal of Drug Targeting;2023-10-26

5. Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition;eBioMedicine;2022-12